EUVIMEDEUVIMED entdecken
Open Access

STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma

Yayan Deng, Xue Liu, Yujuan Huang, Jiaxiang Ye, Qian He, Yue Luo, Yong Chen, Qiuyun Li, Yan Lin, Rong Liang, Yongqiang Li, Jiazhang Wei und 1 weitere

Cellular Oncology · 2023

DOI: 10.1007/s13402-023-00790-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2023. Verfasst von Yayan Deng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning, 530021, China. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Guangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasopharyngeal NeoplasmsEpstein-Barr Virus InfectionsChick EmbryoAnimalsHumansNasopharyngeal CarcinomaHerpesvirus 4, HumanProto-Oncogene Proteins c-aktMAP Kinase Signaling SystemStromal Interaction Molecule 1PhenotypeHuman Umbilical Vein Endothelial CellsCell Line, TumorTumor MicroenvironmentNeoplasm Proteins

Stichwörter der Autor:innen

AngiogenesisLatent membrane protein 1Nasopharyngeal carcinomaStromal interaction molecule 1Tumor-derived exosomes

Substanzen

Proto-Oncogene Proteins c-aktStromal Interaction Molecule 1STIM1 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Medical Oncology, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning, 530021, China.
  • Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Shenzhen, 518055, China.
  • Department of Otolaryngology & Head and Neck, The People's Hospital of Guangxi Zhuang Autonomous Region, 6 Taoyuan Road, Nanning, 530021, China. somnent@gmail.com.
  • Institute of Oncology, Guangxi Academy of Medical Sciences, 6 Taoyuan Road, Nanning, 530021, China. somnent@gmail.com.
  • Department of Medical Oncology, Guangxi Medical University Cancer Hospital, 71 Hedi Road, Nanning, 530021, China. zhangjinyan@gxmu.edu.cn.

Förderung

  • Natural Science Foundation of Guangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Deng, Y., Liu, X., Huang, Y., Ye, J., He, Q., Luo, Y., Chen, Y., Li, Q., Lin, Y., Liang, R., Li, Y., Wei, J., & Zhang, J. (2023). STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-023-00790-0

Vancouver

Deng Y, Liu X, Huang Y, Ye J, He Q, Luo Y, et al. STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma. Cellular Oncology. 2023. doi:10.1007/s13402-023-00790-0

BibTeX
@article{Deng2023,
  author = {Deng, Yayan and Liu, Xue and Huang, Yujuan and Ye, Jiaxiang and He, Qian and Luo, Yue and Chen, Yong and Li, Qiuyun and Lin, Yan and Liang, Rong and Li, Yongqiang and Wei, Jiazhang and Zhang, Jinyan},
  title = {STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma},
  journal = {Cellular Oncology},
  year = {2023},
  doi = {10.1007/s13402-023-00790-0}
}
Kostenlos starten →